HIV and AIDS Trial, Recruiting NCT06267508 Sponsor: Michael Hoelscher Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT06267508
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • The mother must give her own voluntary and informed agreement to take part in the study (if she is participating herself)
  • A parent or legal guardian must give voluntary and informed agreement for the child to take part
  • The mother or legal guardian must be 18 years of age or older
  • The mother must have a confirmed HIV diagnosis on record
  • The mother or legal guardian must agree to HIV testing for the child, and for the mother herself if she is also participating
  • The mother or legal guardian must agree to active follow-up contact, including visits to the home if needed

Who may not be able to join:

  • Mothers who have a condition or difficulty that would make it very hard for her or her baby to take part or to understand the study information
  • Mothers who gave birth more than 72 hours (3 days) before being assessed for the study
  • People who are currently in prison
  • Mothers who are experiencing a medical emergency at the time of assessment that has not been resolved before enrolment
  • Cases where the baby was stillborn
  • Babies who need emergency medical care (such as resuscitation, intensive care after birth, or treatment for severe jaundice), or babies born with a serious physical condition
  • Cases where the doctor responsible for the mother's or baby's care believes that taking part in the study could cause unacceptable risk or hardship — for example, if the baby has a significant birth condition, a serious health problem, or a very low birth weight (under 1,500 grams)
  • Families or individuals who the lead researcher believes are unlikely to be able to follow the study requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +49-89-4400

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Michael Hoelscher
Registry
ClinicalTrials.gov
Start date
30 April 2024
Est. completion
1 December 2025

Where this trial is recruiting

Mozambique Tanzania

Primary endpoints

Proportion of HIV-exposed infants correctly identified as low- or high-risk and receiving birth EID testing and ePNP or ART as appropriate within 7 days of life

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov